Finance

Beta
Lists
JBIO:NASDAQ
Jade Biosciences Inc
$16.94
-4.51%
(-0.80) 1D
$16.94
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JBIO...
Open
$17.52
High
$18.23
Low
$16.51
Mkt. cap
836.16M
Avg. vol.
756.66K
Volume
2.60M
52-wk high
$27.96
52-wk low
$6.56
EPS
-$2.41
Beta
1.45
Shares outstanding
49.36M
No. of employees
55
Open
$17.52
High
$18.23
Low
$16.51
Mkt. cap
836.16M
Avg. vol.
756.66K
Volume
2.60M
52-wk high
$27.96
52-wk low
$6.56
EPS
-$2.41
Beta
1.45
Shares outstanding
49.36M
No. of employees
55
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to JBIO in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for JBIO in the last 3 months.
Highest
Current $16.94
$74.00 (+336.84%)
Average
$49.00 (+189.26%)
Lowest
$40.00 (+136.13%)
News stories
From sources across the web
About Jade Biosciences Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.55M
22.01M
28.54M
36.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23M
5.39M
6.44M
7.39M
Operating expense
27.78M
27.40M
34.98M
43.44M
Total operating expenses
27.78M
27.40M
34.98M
43.44M
Operating income
-27.78M
-27.40M
-34.98M
-43.44M
Other non operating income
-
-28.00K
20.00K
-9.00K
EBT including unusual items
-32.13M
-25.18M
-31.87M
-40.35M
EBT excluding unusual items
-25.95M
-25.18M
-31.87M
-40.35M
Income tax expense
-
-
58.00K
16.00K
Effective tax rate
-
-
-0.18%
-0.04%
Other operating expenses
-
-
-
-
Net income
-32.13M
-25.18M
-31.93M
-40.37M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.83M
2.25M
3.08M
3.10M
Interest expense
-
-
-
-
Net interest expenses
1.83M
2.25M
3.08M
3.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.78M
-27.39M
-34.97M
-43.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more